Search results for "Highlights"
Monofilament test for diagnosing diabetic polyneuropathy has high rate of false negatives
A Norwegian study found that the 5.07/10-g monofilament test was less sensitive in women and in older patients and less specific in patients with neuropathic pain. The study's authors recommended against using the monofilament test to diagnose diabetic polyneuropathy.
https://diabetes.acponline.org/archives/2023/12/08/1.htm
8 Dec 2023
Higher aspirin dose no more effective for CV prevention in high-risk patients with diabetes
A subgroup analysis of a randomized trial found that patients with diabetes and atherosclerotic cardiovascular (CV) disease had similar outcomes whether they took 81 mg or 325 mg of aspirin daily.
https://diabetes.acponline.org/archives/2023/10/13/10.htm
13 Oct 2023
COVID-19 boosters associated with transient increases in glycemia, study finds
A small cohort study of patients with type 1 diabetes who received COVID-19 booster vaccines found significant increases in their blood glucose levels on the second and third day after vaccination.
https://diabetes.acponline.org/archives/2023/10/13/3.htm
13 Oct 2023
CT as effective as angiography as first test for patients with diabetes, chest pain
Patients with diabetes and stable chest pain had no difference in major adverse cardiac events if they underwent cardiac CT first when they were referred for invasive coronary angiography, and they had fewer procedure-related complications with a CT-first strategy.
https://diabetes.acponline.org/archives/2023/10/13/2.htm
13 Oct 2023
Diabetes patients lost more weight with time-restricted eating than calorie counting
Over the course of six months, eating only between noon and 8 p.m. had a greater impact on weight loss and a similar effect on HbA1c levels compared with reducing energy intake by 25%, according to a small randomized trial of patients with type 2 diabetes and obesity.
https://diabetes.acponline.org/archives/2023/11/10/1.htm
10 Nov 2023
Spotlight on diabetes drug class comparisons
A large trial compared insulin, a sulfonylurea, a glucagon-like peptide-1 (GLP-1) receptor agonist, and a dipeptidyl peptidase-4 inhibitor as second-line therapy, while a modeling study considered GLP-1 receptor agonists and sodium-glucose cotransporter-2 inhibitors as first-line agents.
https://diabetes.acponline.org/archives/2022/10/14/5.htm
14 Oct 2022
Younger, leaner patients may have undiagnosed type 2 diabetes, study finds
An analysis of 56 national health surveys throughout the world found that a substantial proportion of patients with a fasting plasma glucose level of 126 mg/dL (7.0 mmol/L) or greater may be younger than age 35 years and/or be in the underweight or normal weight category.
https://diabetes.acponline.org/archives/2023/07/14/3.htm
14 Jul 2023
Liraglutide shows some benefits as adjunctive therapy in type 1 diabetes, review finds
A systematic review and meta-analysis of studies involving four glucagon-like peptide-1 receptor agonists found that liraglutide had the greatest effect on HbA1c level, weight, and total insulin dose, although odds of nausea and ketosis were higher.
https://diabetes.acponline.org/archives/2023/09/08/2.htm
8 Sep 2023
Young adults' lack of regular diabetes care may be linked to beliefs about medication
Follow-up research from the TODAY study found that a quarter of participants, ages 19 to 31 years, lacked a usual place for diabetes care and almost half had an urgent care visit in the past year. Belief in the necessity of medications was associated with regular access to care.
https://diabetes.acponline.org/archives/2023/08/11/2.htm
11 Aug 2023
GLP-1 receptor agonists associated with better primary CV prevention vs. DPP-4 inhibitors
A retrospective study compared cardiovascular (CV) outcomes among patients adding glucagon-like peptide-1 (GLP-1) receptor agonists, sodium-glucose cotransporter-2 inhibitors, or dipeptidyl peptidase-4 (DPP-4) inhibitors to metformin, sulfonylurea, or insulin treatment alone or in combination.
https://diabetes.acponline.org/archives/2023/05/12/3.htm
12 May 2023